Login Request a demo
High severity · published Jun 13, 2023
CVE-2022-47376
The Alaris Infusion Central software, versions 1.1 to 1.3.2, may contain a recoverable password after the installation
7.3
CVSS
0.2%
EPSS
No
On KEV
Description
The Alaris Infusion Central software, versions 1.1 to 1.3.2, may contain a recoverable password after the installation. No patient health data is stored in the database, although some site installations may choose to store personal data.
CVSS vector
CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:L
Attack vector
Local
Complexity
Low
Privileges
Low
User interaction
None
Confidentiality
High
Integrity
High
Availability
Low
Scope
Unchanged
Exploitation
Is it being used?
Exploit prediction (EPSS)0.2% · higher than 5% of CVEs
Exploited in the wildNo evidence yet
CISA KEVNot listed
Ransomware campaign useNot known
Affected products
Which versions
AI
Alaris Infusion Central · BD
1.1 through 1.3.2 · source: NVD
Affected product
AI
Alaris Infusion Central
BD
References
NVD
https://nvd.nist.gov/vuln/detail/CVE-2022-47376
CVE.org
https://www.cve.org/CVERecord?id=CVE-2022-47376
Vendor Advisory
https://www.bd.com/en-us/about-bd/cybersecurity/bulletin/alaris-infusion-central-recoverable-password-vulnerability